Mivebresib | B1564

Mivebresib is a potent BET inhibitor with potential antineoplastic activity. It disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo.

Mivebresib is a potent BET inhibitor with potential antineoplastic activity. It disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo.

B1564 | Mivebresib DataSheet

Alternate Name/Synonyms: N-(4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide; ABBV-075

Appearance: Crystalline solid

Formulation: N/A

CAS Number: 1445993-26-9

Structure Available?: N/A

Peptide sequence: N/A

Salt Form: N/A

Molecular Formula: C₂₂H₁₉F₂N₃O₄S

Molecular Weight: 459.47

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: DMSO

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A potent BET inhibitor

MDL Number: N/A

PubChem CID: 71600087

SMILES: CCS(=O)(=O)NC1=CC(=C(C=C1)OC2=C(C=C(C=C2)F)F)C3=CN(C(=O)C4=C3C=CN4)C

InChi: InChI=1S/C22H19F2N3O4S/c1-3-32(29,30)26-14-5-7-19(31-20-6

InChi Key: RDONXGFGWSSFMY-UHFFFAOYSA-N